评估遗传标记在预测口腔白血病恶性转变中的作用
Ahtesham Ahmad Qurishi1, Mohamed S Mohamed Morsy2, Abeer M Atout2
1Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jizan University, Saudi Arabia.
Journal of pharmacy & bioallied sciences
|July 14, 2025
概括
像p53,cyclin D1和微卫星不稳定性这样的遗传标记可以预测口腔白血病恶性转变. 结合标记物的表达显著增加了口腔状细胞癌的风险.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 口腔医学是指口腔医学.
背景情况:
- 口腔白血病是一种先发性病变,具有可变的口腔状细胞癌 (OSCC) 转变风险.
- 早期识别遗传标记对于及时干预和更好的患者结果至关重要.
研究的目的:
- 调查遗传标记 (p53,cyclin D1,微卫星不稳定性) 对口腔白血病恶性转变的预测价值.
- 评估这些标记物对OSCC风险的综合影响.
主要方法:
- 150名口腔白血病患者的前性队列研究.
- 使用实时PCR和组织病理学分析p53,cyclin D1和微卫星不稳定性的分析.
- 对OSCC转变进行24个月的随访.
主要成果:
- 分别在20%,30%和16.7%的患者中检测到p53,cyclin D1和微卫星不稳定性.
- 恶性转变发生在60%的p53阳性病例和48.9%的环素D1阳性病例中.
- 结合p53和cyclin D1的过度表达与转化风险增加显著相关 (P <0.05).
结论:
- p53,环素D1和微卫星的不稳定性显示出口腔白血病恶性转变的潜在预测因素.
- 综合基因标记分析可能有助于在口腔白血病患者的早期诊断和风险分层.
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Non-LTR Retrotransposons
11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K


